MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Recruiting
Conditions
Intensive Care Unit
Acute Kidney Injury
Ultrasound
Interventions
Other: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound
First Posted Date
2024-04-02
Last Posted Date
2025-02-17
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
44
Registration Number
NCT06341062
Locations
🇨🇳

Department of Ultrasound Diagnosis, Peking University Third Hospital, Beijing, Beijing, China

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Recruiting
Conditions
Liver Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Lung Cancer
Interventions
Radiation: SBRT
First Posted Date
2024-04-02
Last Posted Date
2024-04-02
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
57
Registration Number
NCT06342323
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Lysophosphatidylglycerol in Asthma Pathogenesis

Recruiting
Conditions
Asthma
First Posted Date
2024-03-25
Last Posted Date
2024-03-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
250
Registration Number
NCT06327516
Locations
🇨🇳

Peking university third hospital, Beijing, None Selected, China

Study on the Effect of Telerehabilitation Using Wearable Devices After ACL Reconstruction

Not Applicable
Recruiting
Conditions
Anterior Cruciate Ligament Reconstruction
Interventions
Behavioral: the traditional rehabilitation group
Device: the remote rehabilitation group
First Posted Date
2024-03-25
Last Posted Date
2025-02-12
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
216
Registration Number
NCT06327555
Locations
🇨🇳

quan Jian Wang, Beijing, Beijing, China

A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome

Not Applicable
Recruiting
Conditions
Polycystic Ovary Syndrome (PCOS)
Interventions
Other: lifestyle intervention
Device: acupuncture
Device: Sham acupuncture
First Posted Date
2024-03-12
Last Posted Date
2024-03-12
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
144
Registration Number
NCT06306417
Locations
🇨🇳

Peking University third hospital, Beijing, China

Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children

Phase 4
Recruiting
Conditions
Children
Allergic Disease
Interventions
Other: 1-3 Cetirizine Pharmacokinetic samples
First Posted Date
2024-03-01
Last Posted Date
2024-03-01
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
80
Registration Number
NCT06288334
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Analysis of Prognosis and Risk Factors of LAL Reconstruction Procedure for Patients With AF of the LAL: a Prospective Cohort Study

Active, not recruiting
Conditions
Avulsion Fracture of Lateral Ankle Ligament
Interventions
Procedure: lateral ankle ligament repair or reconstruction
First Posted Date
2024-02-26
Last Posted Date
2024-02-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
120
Registration Number
NCT06277544
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)

Recruiting
Conditions
Biliary Stricture
Bile Duct Cancer
Pancreas Cancer
First Posted Date
2024-02-26
Last Posted Date
2024-07-29
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
99
Registration Number
NCT06277531
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

🇨🇳

Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China

A Prospective Multicenter Cohort Study About Internal Fixation Using PFUN Versus PFNA for Femoral Intertrochanteric Fracture

Not Applicable
Recruiting
Conditions
Femoral Intertrochanteric Fractures
Interventions
Device: PFNA
Device: PFUN
First Posted Date
2024-02-26
Last Posted Date
2024-02-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
130
Registration Number
NCT06277622
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

Phase 4
Recruiting
Conditions
Diabetes
Interventions
Drug: The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach.
First Posted Date
2024-02-22
Last Posted Date
2024-02-22
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
48
Registration Number
NCT06273215
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath